Currently Viewing:
European Society of Cardiology (ESC) 2017
Dr Christi Deaton on the Most Important Steps for Cardiovascular Prevention
November 12, 2017
Currently Reading
Dr John Rumsfeld: We're Just at the Beginning of the Digital Health Transformation
November 09, 2017
Christi Deaton: Challenges of Motivating Patients to Participate in CVD Prevention Strategies
November 04, 2017
Dr John Rumsfeld on the Digital Transformation of Cardiovascular Medicine
October 24, 2017
Dr Deepak Bhatt on the Impact of the COMPASS Trial on Standard of Care
October 19, 2017
Dr Jeanette Stingone: Air Pollution Is an Issue Everywhere in the US
October 12, 2017
Dr John Rumsfeld Outlines ACC's Main Goals for the Future of Cardiology
October 07, 2017
Dr Simon Gibbs Discusses the Future of Pulmonary Hypertension Treatments
October 03, 2017
Dr Steven Nissen Argues for Aggressively Lowering LDL Cholesterol
October 01, 2017
Dr John Eikelboom on the COMPASS Trial Findings
September 28, 2017
Dr John Eikelboom on the Surprising Results of the COMPASS Trial
September 15, 2017
Dr Simon Gibbs Outlines Monotherapy vs Combination Therapy in Pulmonary Hypertension
September 14, 2017
Dr Christi Deaton: Ask Cardiac Patients About Their Diet and Exercise
September 12, 2017
Dr Steven Nissen on Which Patients Should Be Treated With PCSK9 Inhibitors
September 11, 2017
Dr Jeanette Stingone on Lasting Cardiovascular Effects of Prenatal Exposure to Air Pollution
September 07, 2017
Dr Christi Deaton on Promoting Better Self-Management for Patients With CVD
August 29, 2017
Dr John Eikelboom: COMPASS' Rivaroxaban Plus Aspirin Will Become Standard for CAD, PAD
August 29, 2017
Comorbidities in Patients With Heart Failure: Treating the Whole Patient
August 29, 2017
Dr Simon Gibbs on Daily Management of Patients With Pulmonary Hypertension
August 28, 2017

Dr John Rumsfeld: We're Just at the Beginning of the Digital Health Transformation

Digital health, artificial intelligence and machine learning, and precision medicine are the areas where there is the most excitement in innovations for cardiovascular care, said John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.


Digital health, artificial intelligence and machine learning, and precision medicine are the areas where there is the most excitement in innovations for cardiovascular care, said John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.

Transcript (slightly modified)

What evolving technologies in cardiology are you expecting to see make big improvements in care?

When we think about innovations coming to cardiovascular care, and specifically transformation of care delivery, I think the areas where there is the most excitement is in digital health, artificial intelligence and machine learning, and precision health or precision medicine. Now, those cross over with each other, but when I talk about those I’m really talking about things like mobile health, wearable sensors, and then using new data sources, which may include genomics, but also other data sources, like social network data, to have a better sense of predicting risk and then combining those digital health tools with the analytics to have more precise care for patients to keep patients healthier, with a focus on health rather than disease, and a focus on care outside the hospital. All of that is a little bit general, but what I think is, is that we are just at the beginning of the digital health transformation. 

Healthcare started off in kind of tough way because the first digital healthcare transformation was the electronic health record, which for many clinicians and others has been a frustrating experience and has not been adopted as a new medical device might be for a procedure. Well, they were not really designed to be good in terms of digital transformation. They don’t make things easier or more efficient except from a billing code standpoint, for the most part. They will evolve, but what we really hope will evolve is how we are going to integrate new digital health tools, wearable sensors, and so forth, into our care. It’s still unclear how that’s going to happen because right now there’s a lot of consumer products and there are some products being sold at the health system level. But, what hasn’t happened enough yet is the design and development of digital health tools, specifically to help the interface between patients and their families, and clinicians.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!